Preop testing overused in mid urethral sling surgery — 4 key points

In a study published in The Journal of Urology, researchers found preoperative testing for patients undergoing mid urethral sling surgery does not adhere to national guidelines.

Advertisement

Leading study author, Tom S. Feng, MD, from the Cedars Sinai Medical Center in Los Angeles, and colleagues estimated the effect of overuse of preoperative testing on healthcare costs. They reviewed data for women who underwent sling surgery (with or without concomitant prolapse repair) between 2012 and 2013.

Here are four key points:

1. Researchers identified 101 women who underwent mid urethral sling surgery and 346 preoperative test orders.

2. Overall, there was no appropriate clinical indication for 76 percent of coagulation profiles, 73 percent of complete blood counts, 47 percent of basic metabolic panels, 39 percent of chest X-rays and 21 percent of electrocardiograms ordered.

3. Despite an appropriate clinical indication, 6 percent of electrocardiograms, 22 percent of chest X-rays and 10 percent of urinalyses were not ordered.

4. The estimated charges of overused tests were $1,844.15 ($18 per patient).

More articles on healthcare:
Receiving curative surgery for non-small cell lung cancer varies across the US — 5 takeaways
The Wikileaks of healthcare: Could clinical quality transparency improve care?
Connecticut law to clarify outpatient hospital facility fees in 2015: 5 key notes

Advertisement

Next Up in ASC News

  • ASCs have taken center stage of many hospital and health systems’ growth and development strategies in recent years as they…

  • Germantown, Md.-based Capital Surgical Solutions plans to open a new ASC in Portland, Ore., in the fourth quarter of 2026,…

  • Rising volumes and strong demand have masked some of the biggest vulnerabilities facing ASCs.  Six ASC leaders joined Becker’s to…

Advertisement

Comments are closed.